Surrogate biochemical markers: precise measurement for strategic drug and biologics development.
More efficient drug and biologics development is necessary for future success of pharmaceutical and biotechnology companies. One way to achieve this objective is to use rationally selected surrogate markers to improve the early decision-making process. Using typical clinical chemistry methods to measure biochemical markers may not ensure adequate precision and reproducibility. In contrast, using analytical methods that meet good laboratory practices along with rational selection and validation of biochemical markers can give those who use them a competitive advantage over those who do not by providing meaningful data for earlier decision making.
Lee
J W
JW
Harris Laboratories, Inc., Lincoln, Nebraska, USA.
Hulse
J D
JD
Colburn
W A
WA
D001688:Biological Products; D015415:Biomarkers / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D008297:Male; D012107:Research Design
D001688:Biological Products; D015415:Biomarkers